drugset
drugset / Trial / NCT00410254

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

NCT00410254 ↗

Phase 1 Completed 38 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the potential PK interaction of multiple oral doses of HCV-796 and a single oral dose of midazolam when coadministered to healthy subjects.

Timeline

Start
2007-06
Primary completion
—
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule — Oral
Subject NESBUVIR Small molecule — Oral

Indications

No indication recorded.